Navigation Links
RxSafetyMatters Receives 2013 Communicator Award for its Mobile Site
Date:7/19/2013

STAMFORD, Conn., July 19, 2013 /PRNewswire/ -- RxSafetyMatters.org, an online resource about preventing prescription drug abuse, recently received the 2013 Communicator Award (CA) for best mobile site in the category of Health and Wellness.  The CA is the leading international awards program recognizing big ideas in marketing and communications.  Founded nearly two decades ago, CA receives over 6,000 entries from companies and agencies of all sizes, making it one of the largest awards of its kind in the world. 

(Logo:  http://photos.prnewswire.com/prnh/20100921/NY67262 )

(Logo: http://photos.prnewswire.com/prnh/20130719/NY49019LOGO )

Pharmaceutical company Purdue Pharma L.P. developed RxSafetyMatters.org as an online resource to help healthcare professionals, law enforcement personnel, and families and communities learn more about the dangers of illegal trafficking and abuse of prescription medications. The site provides information on programs and resources designed to help deter medication misuse and abuse. The RxSafetyMatters mobile site was introduced in 2012 and enables mobile users to optimize the website on a mobile device such as an iPhone, tablet, or a smartphone with a browser. 

"We thought it was important to design this resource to be mobile friendly given the growing number of people who are using handheld devices to search for information online," said Jim Heins, Senior Director, Public Affairs at Purdue Pharma.  "The mobile site allows users to easily read, download and share the resources offered on the site."

According to a new report from Walker Sands, mobile websites are not commonplace yet, but are steadily gaining popularity – this is because website traffic is increasingly coming through mobile devices. The percentage of website traffic coming from mobile devices jumped from 17.5% in Q3 2012 to 23.1% in Q4 2012.

To learn more about CA, visit http://www.communicatorawards.com

About Purdue Pharma L.P.
Purdue Pharma L.P. is a privately held pharmaceutical company, founded by physicians, that is engaged in the research, development, production, and distribution of prescription and over-the-counter medicines and healthcare products. The company is known for its pioneering research on pain, a principal cause of human suffering. Purdue Pharma L.P. has developed www.RxSafetyMatters.org to provide information and resources to help deter medication misuse and abuse.

About RxSafetyMatters
RxSafetyMatters connects healthcare professionals, families, communities, and law enforcement officials with programs focused on fighting prescription medication abuse and theft. Learn more about RxSafetyMatters at www.rxsafetymatters.org.


'/>"/>
SOURCE Purdue Pharma L.P.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo Receives FDA Tentative Approval For Generic Equivalent To Prandin(R)
2. Elekta Receives CE Marking for Clarity 4D Monitoring
3. SynGen Inc. Receives FDA 510K Clearance to Market SynGenX-1000 Cord Blood Processing Platform
4. Bison Stainless Tube Receives ISO 9001:2008 Certification
5. UCBs Kremers Urban Pharmaceuticals Inc. receives FDA approval for extended release methylphenidate hydrochloride
6. Society for Clinical Research Sites Receives Unprecedented Response from Industry Stakeholders to Support Sites by Joining Corporate Partnership Program
7. Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America
8. HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial
9. Micell Technologies Receives CE Mark Approval for MiStent SES
10. Prime Therapeutics receives highest rating in 2013 customer satisfaction survey
11. KemPharm, Inc. Receives Patent from the USPTO for Novel Pain Drug Candidate, KP201
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Actinic Keratosis Market and ... their offering.       (Logo: ... Market and Competitive Landscape Highlights 2016, provides ... Actinic Keratosis epidemiology, Actinic Keratosis market valuations ...
(Date:5/3/2016)... Research and Markets has announced ... Therapy Market Outlook 2020" report to their offering. ... ,Recombinant technology has improved significantly in past years due ... in coming years. Many cancer drugs have been developed ... are also expected to be developed with its help. ...
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK , ... today announced Food and Drug Administration (FDA) approval ... that provides heart failure patients with access to ... also have remote monitoring with daily automatic transmission ... heart rate in response to physiological demands. ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... 05, 2016 , ... Qrono Inc. , a specialty ... collaboration with the Australian critical medicine company, Phebra Pty Ltd. , to ... medicines can offer improved therapeutic benefits over oral formulations, including better bioavailability, improved ...
(Date:5/5/2016)... ... , ... Einstein Medical is proud to announce that it has ... commentary at the 2016 ASCRS/ASOA Symposium and Congress, which takes place in New Orleans, ... Refractive Surgery and the American Society of Ophthalmic Administrations will be held at the ...
(Date:5/5/2016)... Francisco, CA (PRWEB) , ... May 05, 2016 , ... This weekend, from Friday, May ... will take on steep California terrain at the first Team Semper Fi Mountain Bike Camp, ... Joining them will be mountain bike legends Mark Weir and Jason Moeschler, who’ll share pro ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... Business Journalists , led by the Wharton School’s most prominent professors, help ... one-day program at the Wharton School’s San Francisco campus will feature Wharton ...
(Date:5/5/2016)... ... May 05, 2016 , ... Derrin Doty Group has ... of Bremerton, Port Orchard and communities west of Seattle. The insurance provider’s caring team ... local girl who died suddenly due to complications from the flu, that they have ...
Breaking Medicine News(10 mins):